Abstract:Mutations in transcription factor p63 are associated with developmental disorders that manifest defects in stratified epithelia including the epidermis. The underlying cellular and molecular mechanism is however not yet understood. We established an epidermal commitment model using human induced pluripotent stem cells (iPSCs) and characterized differentiation defects of iPSCs derived from ectrodactyly, ectodermal dysplasia, and cleft lip/palate (EEC) syndrome patients carrying p63 mutations. Transcriptome analyses revealed stepwise cell fate transitions during epidermal commitment: Specification from multipotent simple epithelium to basal stratified epithelia and ultimately to the mature epidermal fate. Differentiation defects of EEC iPSCs caused by p63 mutations occurred during the specification switch from the simple epithelium to the basal-stratified epithelial fate. Single-cell transcriptome and pseudotime analyses of cell states identified mesodermal activation that was associated with the deviated commitment route of EEC iPSCs. Integrated analyses of differentially regulated genes and p63-dependent dynamic genomic enhancers during epidermal commitment suggest that p63 directly controls epidermal gene activation at the specification switch and has an indirect effect on mesodermal gene repression. Importantly, inhibitors of mesodermal induction enhanced epidermal commitment of EEC iPSCs. Our findings demonstrate that p63 is required for specification of stratified epithelia, and that epidermal commitment defects caused by p63 mutations can be reversed by repressing mesodermal induction. This study provides insights into disease mechanisms underlying stratified epithelial defects caused by p63 mutations and suggests potential therapeutic strategies for the disease.

Functional characterization of a novel TP63 mutation in a family with overlapping features of Rapp‐Hodgkin/AEC/ADULT syndromes

TP63 Gene Mutations in Chinese P63 Syndrome Patients

A spectrum of TP63- related disorders with eight affected individuals in five unrelated families

TP63 gene mutation in ADULT syndrome

A Novel Mutation (c.1010g>t; P.r337l) in TP63 As a Cause of Split-Hand/foot Malformation with Hypodontia.

p63 in corneal and epidermal differentiation

Anorectal Malformation Associated with a Mutation in the P63 Gene in a Family with Split Hand–foot Malformation

Familial cleft tongue caused by a unique translation initiation codon variant in TP63

Heterozygous TP63 Mutation in a Chinese Patient with Ectrodactyly-Ectodermal Dysplasia Clefting Syndrome Without Clefting

Tooth Defects of EEC and AEC Syndrome Caused by Heterozygous TP63 Mutations in Three Chinese Families and Genotype‐phenotype Correlation Analyses of TP63‐related Disorders

Next-Generation Sequencing Detection and Characterization of A Heterozygous Novel Splice Junction Mutation in the 2b Domain of Krt1 in A Family with Diffuse Palmoplantar Keratoderma

Single-cell RNA-seq Identifies a Reversible Epithelial-Mesenchymal Transition in Abnormally Specified Epithelia of P63 EEC Syndrome

Alternating Hemiplegia and Epilepsia Partialis Continua: A new phenotype for a novel compound TBC1D24 mutation

Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

Tp63 in Oral Development, Neoplasia, and Autoimmunity

AEC-Associated P63 Mutations Lead to Alternative Splicing/Protein Stabilization of P63 and Modulation of Notch Signaling

Identification and functional characterization of two new transcriptional variants of the human p63 gene

Molecular and Cellular Function of p63 in Skin Development and Genetic Diseases

Analysis Of Large Phenotypic Variability Of Eec And Shfm4 Syndromes Caused By K193e Mutation Of The Tp63 Gene

P63 in health and cancer

Regulation of skin aging and heart development by TAp63